|
NAMS is pleased to announce the following educational programs available on Medscape.com, the well-received outcome of our educational collaboration with this robust destination site that offers original medical content and educational tools for healthcare professionals. In the coming months, as more collaborative projects become available on the Medscape site, we'll post them here; or you can access them directly at Medscape.com.
Medscape Partners Page: NAMS is honored to have been chosen by Medscape to host its own special page on the popular Medscape.com site. Examples of First to Know®, Menopause articles, and NAMS Position Statements will be refreshed monthly. Also featured will be links to new NAMS/Medscape educational collaborations as they are posted.
| How to View: To view the NAMS special page on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
the NAMS dedicated page. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
Educational Programs: The following educational programs are available on Medscape.com. For more information on a specific educational program, click on your choice from the following list:
- Spotlight Program: “Postmenopausal Systemic Hormone Therapy: Putting Risks Into Perspective”
- Expert Viewpoint: “The Beneficial Effect of Hormone Therapy on Mortality and Coronary Heart Disease
in Younger Versus Older Postmenopausal Women”
- Expert Interview: “Hormone Therapy and Breast Cancer: An Expert Interview With
JoAnn E. Manson, MD, DrPH"
- Town Hall Webcast: “Postmenopausal Systemic Hormone Therapy: Reaching Consensus at Last
on Benefit and Risk”
- Clinical Update: “The Practical Clinical Application of the NAMS 2008 Position Statement on Estrogen and Progestogen Use in Postmenopausal Women”
- Test & Teach: “Managing Vasomotor Symptoms in Women With Cardiovascular Risk”
- Test & Teach: “Selecting Menopausal Estrogen Therapy: Oral or Transdermal?”
- Symposium Highlights: “Comprehensive Breast Care: An Update for the Menopause Practitioner”
- Spotlight Program: “Dialogues in Menopause Management: Facilitating Counseling About
Hormone Therapy”
- Test & Teach: “Dialogues in Menopause Management: Case-Based Approach to Counseling Patients About Hormone Therapy”
- Test & Teach: “Dialogues in Menopause Management: Counseling Postmenopausal Women About Initiating Estrogen Use for Severe Vasomotor Symptoms and Osteoporosis Prevention”
- Expert Interview: “Conveying Risks and Benefits of Hormone Therapy -- The Challenge for Practitioners: An Expert Interview With Cynthia A. Stuenkel, MD, NCMP”
This live video focuses on the benefit-risk ratio of postmenopausal systemic hormone therapy (HT) and why providers and their patients are concerned. A distinguished panel of experts discusses the latest data regarding HT risks and how clinicians can explain these concepts to patients.
Faculty:
Wulf H. Utian, MD, PhD, DSc(Med)
Executive Director, The North American Menopause Society (NAMS)
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant in Obstetrics and Gynecology
Cleveland Clinic
Cleveland, Ohio
Howard N. Hodis, MD
Harry J. Bauer and Dorothy Bauer Rawlins Professor of Cardiology
Professor of Medicine and Preventive Medicine
Professor of Molecular Pharmacology and Toxicology
Director, Atherosclerosis Research Unit
Division of Cardiovascular Medicine
Keck School of Medicine
University of Southern California
Los Angeles, California
Rogerio A. Lobo, MD
Professor of Obstetrics and Gynecology
Columbia University
New York, New York
Charles L. Loprinzi, MD
Professor of Oncology
Mayo Clinic College of Medicine
Rochester, Minnesota
Susan J. Wysocki, RNC, NP, FAANP
President and CEO
National Association of Nurse Practitioners in Women's Health (NPWH)
Washington, DC
Posted: January 31, 2008
Sponsors: The North American Menopause Society (NAMS), the Association of Nurse Practitioners in Women's health (NPWH), and Medscape.
Disclaimer: Comments made in this activity are individual opinions and do not necessarily reflect the view of NAMS, NPWH, or Medscape.
Supporter Attribution: This activity is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit: Expired
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
Although the public portrayal of hormone therapy (HT) as a preventive therapy is negative, the actual data paint an opposite picture when viewed for the appropriate subgroup of women.
Authors:
Howard N. Hodis, MD
Harry J. Bauer and Dorothy Bauer Rawlins Professor of Cardiology
Professor of Medicine and Preventive Medicine
Professor of Molecular Pharmacology and Toxicology
Director, Atherosclerosis Research Unit
Division of Cardiovascular Medicine
Keck School of Medicine
University of Southern California
Los Angeles, California
Wendy J. Mack, PhD
Associate Professor
Keck School of Medicine
University of Southern California
Los Angeles, California
Posted: February 29, 2008
Sponsors: The North American Menopause Society (NAMS), and Medscape.
Disclaimer: Comments made in this activity are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This activity is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: No
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
In this NAMS-Medscape educational collaboration, Dr. Manson shares her views on menopause management in primary care, specifically focusing on the current evidence on the risk of breast cancer associated with HT during menopause.
Author:
JoAnn E. Manson, MD, DrPH
Professor of Medicine and Elizabeth Fay Brigham Professor of Women's Health
Harvard Medical School
Chief, Division of Preventive Medicine
Co-Director of the Connors Center for Women's Health and Gender Biology
Brigham and Women's Hospital
Boston, MA
Posted: April 30, 2008
Sponsors: The North American Menopause Society (NAMS), and Medscape.
Disclaimer: Comments made in this article are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This article is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: No
| How to View: To view this article on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
This live video and slides captures an expert panel discussing the latest data on benefits and risks of postmenopausal systemic hormone therapy (HT). Questions from the audience about cardiovascular and breast cancer concerns are answered and clarified.
Faculty:
Wulf H. Utian, MD, PhD, DSc(Med)
Executive Director, The North American Menopause Society (NAMS)
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant in Obstetrics, Gynecology, and Women’s Health Institute
Cleveland Clinic
Cleveland, Ohio
Howard N. Hodis, MD
Harry J. Bauer and Dorothy Bauer Rawlins Professor of Cardiology
Professor of Medicine and Preventive Medicine
Professor of Molecular Pharmacology and Toxicology
Director, Atherosclerosis Research Unit
Division of Cardiovascular Medicine
Keck School of Medicine
University of Southern California
Los Angeles, California
Rogerio A. Lobo, MD
Professor of Obstetrics and Gynecology
Columbia University
New York, New York
Cynthia A. Stuenkel, MD
Clinical Professor of Medicine
University of California, San Diego
La Jolla, CA
Posted: June 25, 2008
Sponsors: The North American Menopause Society (NAMS), the Association of Nurse Practitioners in Women's health (NPWH), and Medscape.
Disclaimer: Comments made in this activity are individual opinions and do not necessarily reflect the view of NAMS, NPWH, or Medscape.
Supporter Attribution: This activity is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 1 AMA PRA Category 1 Credits™ for physicians; Nurses - 1 nursing contact hours (1 contact hours are in the area of pharmacology). Valid for credit through
June 30, 2009.
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
Highlights and personal clinical interpretations by Dr. Wulf Utian about the recently published
NAMS 2008 Hormone Therapy Position Statement.
Faculty:
Wulf H. Utian, MD, PhD, DSc(Med)
Executive Director, The North American Menopause Society (NAMS)
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant in Obstetrics, Gynecology, and Women’s Health Institute
Cleveland Clinic
Cleveland, Ohio
Posted: July 25, 2008
Sponsors: The North American Menopause Society (NAMS), the Association of Nurse Practitioners in Women's health (NPWH), and Medscape.
Disclaimer: Comments made in this activity are individual opinions and do not necessarily reflect the view of NAMS, NPWH, or Medscape.
Supporter Attribution: This activity is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 1 AMA PRA Category 1 Credits™ for physicians; Nurses - 1 nursing contact hour (1 contact hour in the area of pharmacology). Valid for credit through
July 25, 2009.
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
An interactive CME activity focusing on the case of a symptomatic postmenopausal woman at risk for cardiovascular disease.
Faculty:
Wulf H. Utian, MD, PhD, DSc(Med)
Executive Director, The North American Menopause Society (NAMS)
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant in Obstetrics, Gynecology, and Women’s Health Institute
Cleveland Clinic
Cleveland, Ohio
Posted: July 25, 2008
Sponsors: The North American Menopause Society (NAMS), the Association of Nurse Practitioners in Women's health (NPWH), and Medscape.
Disclaimer: Comments made in this activity are individual opinions and do not necessarily reflect the view of NAMS, NPWH, or Medscape.
Supporter Attribution: This activity is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 1 AMA PRA Category 1 Credits™ for physicians; Nurses - 1 nursing contact hour (1 contact hour in the area of pharmacology). Valid for credit through
July 25, 2009.
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
An interactive CME activity focusing on the case of a symptomatic early postmenopausal woman considering the selection of oral versus transdermal estrogen therapy.
Faculty:
Robert A. Wild, MD, PhD, MPH
Professor of Reproductive Endocrinology
Adjunct Professor of Biostatistics and Epidemiology
Adjunct Professor of Medicine (Cardiology)
Oklahoma University Health Sciences Center
Oklahoma City, Oklahoma
Posted: September 22, 2008
Sponsor: The North American Menopause Society (NAMS).
Disclaimer: Comments made in this Test & Teach are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: Supported by an independent educational grant from Ther-Rx Corporation, a subsidiary of KV Pharmaceutical.
Continuing Education Credit Offered: Physicians - maximum of 1 AMA PRA Category 1 Credits™ for physicians. Valid for credit through September 22, 2009.
| How to View: To view this activity on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
These “Symposium Highlights” are live videotaped lectures of the primary teaching points culled from the NAMS Postgraduate Course on breast care for the peri- and postmenopausal woman, presented by four leading breast cancer experts at the 2009 NAMS Annual Meeting in Orlando.
Faculty:
Anees B. Chagpar, MD, MSc, MPH
Associate Professor, Division of Surgical Oncology
Director, Multidisciplinary Breast Program
James Graham Brown Cancer Center
University of Louisville
Louisville, KY
Kevin S. Hughes, MD, FACS
Co-Director, Avon Foundation Comprehensive Breast Evaluation Center
Massachusetts General Hospital
Associate Professor of Surgery
Harvard Medical School
Boston, MA
Jules H. Sumkin, DO, FACR
Professor of Radiology
University of Pittsburgh School of Medicine
Chief of Radiology, Magee-Womens Hospital
Pittsburgh, PA
Victor G. Vogel, MD, MHS
Professor of Medicine and Epidemiology
University of Pittsburgh School of Medicine
Co-Director, University of Pittsburgh Cancer Institute Biochemoprevention Program
Director, UPCI/Magee-Womens Hospital Breast Cancer Prevention Program
Pittsburgh, PA
Posted: December 4, 2008
Sponsor: The North American Menopause Society (NAMS)
Disclaimer: Comments made in this program are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: Supported by an independent educational grant from Eli Lilly and Company.
Continuing Education Credit Offered: Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians. Valid for credit through December 4, 2009.
| How to View: To view this video on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
This live video focuses on counseling patients about hormone therapy (HT). A panel of experts presents case studies and explains the best ways to explain this complicated subject to individual patients.
Faculty:
Wulf H. Utian, MD, PhD, DSc(Med)
Executive Director, The North American Menopause Society (NAMS)
Arthur H. Bill Professor Emeritus of Reproductive Biology
Case Western Reserve University School of Medicine
Chairman, Advisory Board, Rapid Medical Research
Consultant in Obstetrics and Gynecology
Cleveland Clinic
Cleveland, Ohio
Elizabeth Contestabile, RN, BScN
Nurse Educator
Shirley E. Greenberg Women’s Health Centre
The Ottawa Hospital, Riverside Campus
Ottawa, Ontario, Canada
Bruce Ettinger, MD
Emeritus Clinical Professor of Medicine
University of California, San Francisco
Adjunct Investigator
Division of Research
Kaiser Permanente Medical Care Program
Oakland, California
Peter F. Schnatz, DO, FACOG
Associate Professor of Obstetrics and Gynecology and Internal Medicine
Director of Medical Student Education Department of Ob/Gyn
The University of Connecticut School of Medicine
Farmington, Connecticut
Director of the Women’s Life Center, Hartford Hospital
Hartford, Connecticut
Posted: December 19, 2008
Sponsors: The North American Menopause Society (NAMS and Medscape.
Disclaimer: Comments made in this Spotlight are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This article is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians; Nurses - 0.5 nursing contact hours (0.5 contact hours are in the area of pharmacology). Valid for credit through
December 19, 2009.
| How to View: To view this video on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
An interactive CME activity with a live clinician-patient vignette and graphics, focusing on how to counsel a postmenopausal woman suffering from severe discomfort due to vaginal atrophy who is considering local vaginal estrogen therapy.
Faculty:
Holly L. Thacker, MD, FACP
Director, Center for Specialized Women's Health
Cleveland Clinic
Associate Professor of Surgery
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, Ohio
Posted: January 12, 2009
Sponsors: The North American Menopause Society (NAMS) and Medscape.
Disclaimer: Comments made in this program are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This article is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians; Nurses - 0.5 nursing contact hours (0.5 contact hours are in the area of pharmacology). Valid for credit through
January 12, 2010.
| How to View: To view this video on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
An interactive CME activity with a live clinician-patient vignette and graphics, focusing on how to counsel a recently postmenopausal woman, who had a hysterectomy, and is now suffering from severe vasomotor symptoms and considering estrogen therapy.
Faculty:
Steven R. Goldstein, MD
Professor of Obstetrics and Gynecology
New York University School of Medicine
Director of Gynecologic Ultrasound
Co-Director of Bone Densitometry
New York University Medical Center.
New York, NY
Posted: June 4, 2009
Sponsors: The North American Menopause Society (NAMS) and Medscape.
Disclaimer: Comments made in this program are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This article is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians; Nurses - 0.5 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology). Valid for credit through
June 4, 2010.
| How to View: To view this video on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
An interview with the new NAMS President in which she shares her views on how to use evidence-based medicine when counseling women about hormone therapy.
Author:
Cynthia A. Stuenkel, MD, NCMP
Clinical Professor of Medicine
University of California, San Diego
La Jolla, California
Posted: September 29, 2009
Sponsors: The North American Menopause Society (NAMS) and Medscape.
Disclaimer: Comments made in this interview are individual opinions and do not necessarily reflect the view of NAMS or Medscape.
Supporter Attribution: This article is supported by an independent educational grant to Medscape from Wyeth.
Continuing Education Credit Offered: No
| How to View: To view this video on the Medscape Web site, click here.
IMPORTANT: Please note that Medscape is an open site to anyone, but requires one-time registration to view
a full-text article. If you are not already registered, it’s fast and free. Go to www.Medscape.com and click on any article title, and registration instructions will follow. All information you are asked to provide is used only in aggregate form.
|
|